Welcome Guest | Register / Login

Asia Pacific Stem Cell Market Forecast 2021-2028

Table of Contents

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Key Drivers
3.1.1. Surging Demand Of Stem Cells In Regenerative Medicine
3.1.2. Growing R&D Investments In Stem Cell Therapies And Research
3.1.3. Rising Awareness About Umbilical Cord Stem Cells
3.1.4. Reduced Risk Of Tissue Rejection In Transplants
3.1.5. Technological Advancements
3.2. Key Restraints
3.2.1. Stringent Government Regulations
3.2.2. High Cost Associated With Stem Cell Procedures
3.2.3. Ethical Issues And Social Complexities Associated With Stem Cells
3.2.4. Less Responsiveness In The Developed Economies
4. Key Analytics
4.1. Porter's Five Forces Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer's Power
4.1.4. Supplier's Power
4.1.5. Competitive Rivalry
4.2. Impact Of Covid-19 On Stem Cell Market
4.3. Value Chain Analysis
4.4. Key Buying Criteria
4.5. History Of Stem Cell
4.6. Regulatory Framework
4.7. Opportunity Matrix
4.8. Vendor Landscape
4.9. Key Investment Insights
5. Market By Therapeutic Application
5.1. Orthopedic Treatments
5.2. Injuries And Wounds
5.3. Oncology Disorders
5.4. Cardiovascular Disorders
5.5. Neurological Disorders
5.6. Diabetes
5.7. Other Therapeutic Applications
6. Market By Product
6.1. Adult Stem Cell
6.1.1. Hematopoietic Stem Cell
6.1.2. Neural Stem
6.1.3. Umbilical Cord Stem Cell
6.1.4. Mesenchymal Stem Cell
6.1.5. Dental Stem Cell
6.2. Human Embryonic Stem Cell
6.3. Pluripotent
6.4. Mouse/Rat Neural
7. Market By Technology
7.1. Acquisition
7.1.1. Stem Cell Bone Marrow Market
7.1.2. Stem Cell Apheresis
7.1.3. Stem Cell Umbilical Cord
7.2. Cryopreservation
7.3. Expansion And Sub-Culture
7.4. Production
7.4.1. Stem Cell Culture
7.4.2. Therapeutic Cloning
7.4.3. Ivf
8. Market By Application
8.1. Regenerative Medicine
8.2. Drug Discovery And Development
9. Market By Treatment Type
9.1. Allogeneic Stem Cell Therapy
9.2. Autologic Stem Cell Therapy
9.3. Syngeneic Stem Cell Therapy
10. Geographical Analysis
10.1. Asia Pacific
10.1.1. Market Size & Estimates
10.1.2. Key Growth Enablers
10.1.3. Key Challenges
10.1.4. Key Players
10.1.5. Country Analysis
10.1.5.1. China
10.1.5.2. Japan
10.1.5.3. India
10.1.5.4. Australia & New Zealand
10.1.5.5. South Korea
10.1.5.6. Thailand
10.1.5.7. Indonesia
10.1.5.8. Vietnam
10.1.5.9. Rest Of Asia Pacific
11. Competitive Landscape
11.1. Key Strategic Developments
11.1.1. Merger & Acquisitions
11.1.2. Product Launch & Developments
11.1.3. Partnership, Contract/Agreement & Collaboration
11.1.4. Business Expansion/ Approval/ Announcement
11.2. Company Profile
11.2.1. Allcells Llc
11.2.2. Becton, Dickinson And Company (Bd)
11.2.3. Corning Inc
11.2.4. Cytori Therapeutics
11.2.5. Ge Healthcare
11.2.6. International Stem Cell Corp
11.2.7. Merck Kgaa (Sigma Aldrich)
11.2.8. Miltenyi Biotec
11.2.9. Pluristem Therapeutics Inc
11.2.10. Qiagen Nv
11.2.11. Smith & Nephew Plc
11.2.12. Stemcell Technologies
11.2.13. Stryker Corporation
11.2.14. Takara Holdings Inc
11.2.15. Thermo Fisher Scientific Inc

List of Tables

Table 1: Market Snapshot - Stem Cell
Table 2: Asia Pacific Stem Cell Market, By Therapeutic Application, Historical Years, 2016-2020 (In $ Million)
Table 3: Asia Pacific Stem Cell Market, By Therapeutic Application, Forecast Years, 2021-2028 (In $ Million)
Table 4: Asia Pacific Stem Cell Market, By Product, Historical Years, 2016-2020 (In $ Million)
Table 5: Asia Pacific Stem Cell Market, By Product, Forecast Years, 2021-2028 (In $ Million)
Table 6: Asia Pacific Adult Stem Cell Market, By Types, Historical Years, 2016-2020 (In $ Million)
Table 7: Asia Pacific Adult Stem Cell Market, By Types, Forecast Years, 2021-2028 (In $ Million)
Table 8: Asia Pacific Stem Cell Market, By Technology, Historical Years, 2016-2020 (In $ Million)
Table 9: Asia Pacific Stem Cell Market, By Technology, Forecast Years, 2021-2028 (In $ Million)
Table 10: Asia Pacific Acquisition Market, By Types, Historical Years, 2016-2020 (In $ Million)
Table 11: Asia Pacific Acquisition Market, By Types, Forecast Years, 2021-2028 (In $ Million)
Table 12: Asia Pacific Production Market, By Types, Historical Years, 2016-2020 (In $ Million)
Table 13: Asia Pacific Production Market, By Types, Forecast Years, 2021-2028 (In $ Million)
Table 14: Asia Pacific Stem Cell Market, By Application, Historical Years, 2016-2020 (In $ Million)
Table 15: Asia Pacific Stem Cell Market, By Application, Forecast Years, 2021-2028 (In $ Million)
Table 16: Asia Pacific Stem Cell Market, By Treatment Type, Historical Years, 2016-2020 (In $ Million)
Table 17: Asia Pacific Stem Cell Market, By Treatment Type, Forecast Years, 2021-2028 (In $ Million)
Table 18: Asia Pacific Stem Cell Market, By Country, Historical Years, 2016-2020 (In $ Million)
Table 19: Asia Pacific Stem Cell Market, By Country, Forecast Years, 2021-2028 (In $ Million)
Table 20: Leading Players Operating In Asia Pacific Stem Cell Market

List of Figures

Figure 1: Porter's Five Force Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: Asia Pacific Stem Cell Market, By Therapeutic Application, In 2020
Figure 6: Asia Pacific Stem Cell Market, By Orthopedic Treatments, 2021-2028 (In $ Million)
Figure 7: Asia Pacific Stem Cell Market, By Injuries And Wounds, 2021-2028 (In $ Million)
Figure 8: Asia Pacific Stem Cell Market, By Oncology Disorders, 2021-2028 (In $ Million)
Figure 9: Asia Pacific Stem Cell Market, By Cardiovascular Disorders, 2021-2028 (In $ Million)
Figure 10: Asia Pacific Stem Cell Market, By Neurological Disorders, 2021-2028 (In $ Million)
Figure 11: Asia Pacific Stem Cell Market, By Diabetes, 2021-2028 (In $ Million)
Figure 12: Asia Pacific Stem Cell Market, By Other Therapeutic Applications, 2021-2028 (In $ Million)
Figure 13: Asia Pacific Stem Cell Market, By Product, In 2020
Figure 14: Asia Pacific Stem Cell Market, By Adult Stem Cell, 2021-2028 (In $ Million)
Figure 15: Asia Pacific Stem Cell Market, By Hematopoietic Stem Cell, 2021-2028 (In $ Million)
Figure 16: Asia Pacific Stem Cell Market, By Neural Stem, 2021-2028 (In $ Million)
Figure 17: Asia Pacific Stem Cell Market, By Umbilical Cord Stem Cell, 2021-2028 (In $ Million)
Figure 18: Asia Pacific Stem Cell Market, By Mesenchymal Stem Cell, 2021-2028 (In $ Million)
Figure 19: Asia Pacific Stem Cell Market, By Dental Stem Cell, 2021-2028 (In $ Million)
Figure 20: Asia Pacific Stem Cell Market, By Human Embryonic Stem Cell, 2021-2028 (In $ Million)
Figure 21: Asia Pacific Stem Cell Market, By Pluripotent, 2021-2028 (In $ Million)
Figure 22: Asia Pacific Stem Cell Market, By Mouse/Rat Neural, 2021-2028 (In $ Million)
Figure 23: Asia Pacific Stem Cell Market, By Technology, In 2020
Figure 24: Asia Pacific Stem Cell Market, By Acquisition, 2021-2028 (In $ Million)
Figure 25: Asia Pacific Stem Cell Market, By Stem Cell Bone Marrow Market, 2021-2028 (In $ Million)
Figure 26: Asia Pacific Stem Cell Market, By Stem Cell Apheresis, 2021-2028 (In $ Million)
Figure 27: Asia Pacific Stem Cell Market, By Stem Cell Umbilical Cord, 2021-2028 (In $ Million)
Figure 28: Asia Pacific Stem Cell Market, By Cryopreservation, 2021-2028 (In $ Million)
Figure 29: Asia Pacific Stem Cell Market, By Expansion And Sub-Culture, 2021-2028 (In $ Million)
Figure 30: Asia Pacific Stem Cell Market, By Production, 2021-2028 (In $ Million)
Figure 31: Asia Pacific Stem Cell Market, By Stem Cell Culture, 2021-2028 (In $ Million)
Figure 32: Asia Pacific Stem Cell Market, By Therapeutic Cloning, 2021-2028 (In $ Million)
Figure 33: Asia Pacific Stem Cell Market, By Ivf, 2021-2028 (In $ Million)
Figure 34: Asia Pacific Stem Cell Market, By Application, In 2020
Figure 35: Asia Pacific Stem Cell Market, By Regenerative Medicine, 2021-2028 (In $ Million)
Figure 36: Asia Pacific Stem Cell Market, By Drug Discovery And Development, 2021-2028 (In $ Million)
Figure 37: Asia Pacific Stem Cell Market, By Treatment Type, In 2020
Figure 38: Asia Pacific Stem Cell Market, By Allogeneic Stem Cell Therapy, 2021-2028 (In $ Million)
Figure 39: Asia Pacific Stem Cell Market, By Autologic Stem Cell Therapy, 2021-2028 (In $ Million)
Figure 40: Asia Pacific Stem Cell Market, By Syngeneic Stem Cell Therapy, 2021-2028 (In $ Million)
Figure 41: Asia Pacific Stem Cell Market, Country Outlook, 2020 & 2028 (In %)
Figure 42: China Stem Cell Market, 2021-2028 (In $ Million)
Figure 43: Japan Stem Cell Market, 2021-2028 (In $ Million)
Figure 44: India Stem Cell Market, 2021-2028 (In $ Million)
Figure 45: Australia & New Zealand Stem Cell Market, 2021-2028 (In $ Million)
Figure 46: South Korea Stem Cell Market, 2021-2028 (In $ Million)
Figure 47: Thailand Stem Cell Market, 2021-2028 (In $ Million)
Figure 48: Indonesia Stem Cell Market, 2021-2028 (In $ Million)
Figure 49: Vietnam Stem Cell Market, 2021-2028 (In $ Million)
Figure 50: Rest Of Asia Pacific Stem Cell Market, 2021-2028 (In $ Million)
Single User License: This License type does not allow the report to be Printed.
Five User License: This License type does not allow the report to be Printed.
Enterprise License: This License type does not allow the report to be Printed.
Why http://www.marketreportsonline.com/
Published By :Inkwood Research
Price
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy